Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. Financials
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
Delayed Quote. Delayed London Stock Exchange - 09/24 11:39:22 am
1388 GBX   -1.84%
09/24GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/24European ADRs Move Lower in Friday Trading
MT
09/24GLAXOSMITHKLINE : UBS sticks Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 73 28988 05166 80169 468--
Entreprise Value (EV)1 94 910113 77387 58190 35488 87785 941
P/E ratio 20,2x19,2x11,8x18,2x15,2x12,7x
Yield 5,36%4,50%5,96%5,76%3,84%3,93%
Capitalization / Revenue 2,38x2,61x1,96x2,09x1,98x1,90x
EV / Revenue 3,08x3,37x2,57x2,71x2,53x2,35x
EV / EBITDA 9,03x9,51x9,19x9,32x8,46x7,60x
Price to Book 16,8x7,35x4,58x4,58x4,30x3,69x
Nbr of stocks (in thousands) 4 914 7954 949 4654 977 7315 004 931--
Reference price (GBP) 14,917,813,413,913,913,9
Announcement Date 02/06/201902/05/202002/03/2021---
1 GBP in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 30 82133 75434 09933 30735 07736 626
EBITDA1 10 50811 9689 5309 69610 51111 310
Operating profit (EBIT)1 8 7458 9728 9068 2209 06010 012
Operating Margin 28,4%26,6%26,1%24,7%25,8%27,3%
Pre-Tax Profit (EBT)1 4 8006 2216 9685 6837 2098 500
Net income1 3 6234 6455 7493 8574 7195 575
Net margin 11,8%13,8%16,9%11,6%13,5%15,2%
EPS2 0,740,931,140,760,911,09
Dividend per Share2 0,800,800,800,800,530,55
Announcement Date 02/06/201902/05/202002/03/2021---
1 GBP in Million
2 GBP
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 8 7397 4188 0928 6898 8617 891
EBITDA1 2 1112 0412 8222 7712 445-
Operating profit (EBIT)1 1 8171 8812 1582 2841 8382 266
Operating Margin 20,8%25,4%26,7%26,3%20,7%28,7%
Pre-Tax Profit (EBT) 8211 5181 470---
Net income1 6771 0731 395866-270-
Net margin 7,75%14,5%17,2%9,96%-3,05%-
EPS2 0,130,210,280,190,01-
Dividend per Share ------
Announcement Date 02/03/202104/28/202107/28/2021---
1 GBP in Million
2 GBP
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 21 62125 72220 78020 88519 40816 473
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,06x2,15x2,18x2,15x1,85x1,46x
Free Cash Flow1 5 6925 0735 4064 2315 4896 337
ROE (Net Profit / Equities) 273%75,0%44,4%34,8%35,7%34,5%
Shareholders' equity1 1 3256 19112 95111 07313 22916 141
ROA (Net Profit / Asset) 10,3%8,90%7,18%5,28%6,09%7,07%
Assets1 35 32552 18580 06273 01077 54878 883
Book Value Per Share2 0,892,422,933,033,233,76
Cash Flow per Share2 1,691,601,681,111,311,53
Capex1 1 3441 2651 2261 4181 4681 520
Capex / Sales 4,36%3,75%3,60%4,26%4,19%4,15%
Announcement Date 02/06/201902/05/202002/03/2021---
1 GBP in Million
2 GBP
Key data
Capitalization (GBP) 69 468 448 484
Capitalization (USD) 94 961 927 556
Net sales (GBP) 34 099 000 000
Net sales (USD) 46 612 651 020
Number of employees 94 066
Sales / Employee (GBP) 362 501
Sales / Employee (USD) 495 531
Free-Float 92,2%
Free-Float capitalization (GBP) 64 066 862 631
Free-Float capitalization (USD) 87 578 071 781
Avg. Exchange 20 sessions (GBP) 8 069 421 083
Avg. Exchange 20 sessions (USD) 11 030 737 231
Average Daily Capital Traded 11,62%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA